ATE241012T1 - Verfahren zur herstellung von humanen relaxin - Google Patents

Verfahren zur herstellung von humanen relaxin

Info

Publication number
ATE241012T1
ATE241012T1 AT94920786T AT94920786T ATE241012T1 AT E241012 T1 ATE241012 T1 AT E241012T1 AT 94920786 T AT94920786 T AT 94920786T AT 94920786 T AT94920786 T AT 94920786T AT E241012 T1 ATE241012 T1 AT E241012T1
Authority
AT
Austria
Prior art keywords
producing human
human relaxin
relaxin
prorelaxin
naturally occurring
Prior art date
Application number
AT94920786T
Other languages
English (en)
Inventor
Tim Breece
Kirk Hayenga
Ernst Rinderknecht
Richard Vandlen
Daniel Yansura
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE241012T1 publication Critical patent/ATE241012T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/64Relaxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT94920786T 1993-06-21 1994-06-20 Verfahren zur herstellung von humanen relaxin ATE241012T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8035493A 1993-06-21 1993-06-21
PCT/US1994/006997 WO1995000645A2 (en) 1993-06-21 1994-06-20 Process for producing relaxin

Publications (1)

Publication Number Publication Date
ATE241012T1 true ATE241012T1 (de) 2003-06-15

Family

ID=22156855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920786T ATE241012T1 (de) 1993-06-21 1994-06-20 Verfahren zur herstellung von humanen relaxin

Country Status (8)

Country Link
US (1) US5759807A (de)
EP (1) EP0707650B1 (de)
JP (2) JP3954091B2 (de)
AT (1) ATE241012T1 (de)
AU (1) AU691189B2 (de)
CA (1) CA2165781C (de)
DE (1) DE69432704T2 (de)
WO (1) WO1995000645A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US5959075A (en) * 1996-08-02 1999-09-28 Zymogenetics, Inc. Testis-specific insulin homolog polypeptides
US6709659B1 (en) 1996-08-02 2004-03-23 Zymogenetics, Inc. Antibodies that bind testis-specific insulin homolog polypeptides
US6251863B1 (en) 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
JP2003514532A (ja) * 1999-11-19 2003-04-22 トランスカーヨティック セラピーズ インコーポレイテッド 生成物の産生量を最適化するための核酸構築体
US20050032683A1 (en) 2000-10-04 2005-02-10 Amento Edward P. Methods of modulating apoptosis by administration of relaxin agonists or antagonists
US20040006205A1 (en) * 2001-04-03 2004-01-08 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20050186526A1 (en) * 2002-11-01 2005-08-25 Bas Medical, Inc. Methods and systems for enabling and stabilizing tooth movement
US7878978B2 (en) * 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
US20050287519A1 (en) * 2004-05-12 2005-12-29 Merchiers Pascal G Methods, compositions and compound assays for inhibiting amyloid-beta protein production
CA2576030A1 (en) * 2004-08-09 2006-02-23 Alios Biopharma Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
MX336145B (es) 2008-05-16 2016-01-08 Corthera Inc Metodo para el tratamiento de insuficiencia cardiaca cronica.
WO2009140659A2 (en) 2008-05-16 2009-11-19 Corthera, Inc. Method of treating dyspnea associated with acute heart failure
US8293100B2 (en) 2009-03-13 2012-10-23 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
GR1006941B (el) 2009-06-01 2010-08-27 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Πεπτιδικη συνθεση (peptide synthesis)
US20130053318A1 (en) 2010-03-10 2013-02-28 Parry Laura Modulating aquaporins with relaxin
SMT201900495T1 (it) 2010-08-17 2019-11-13 Ambrx Inc Polipeptidi di relaxina modificati e loro usi
EP2739647B1 (de) 2011-08-04 2016-07-20 Relaxera GmbH & Co. KG i.G. c/o Immundiagnostik AG Verfahren zur herstellung von humanem relaxin-2
CN102643825A (zh) * 2011-11-18 2012-08-22 上海佑科生物技术有限公司 松弛素野生型和突变体的制备方法及其所制备的松弛素野生型和突变体
EP2630964A1 (de) 2012-02-22 2013-08-28 Immundiagnostik AG Verfahren und Medikation zur Behandlung von Patienten mit Risiko für Prädiabetes und Typ-2-Diabetes
CN102603888B (zh) * 2012-04-11 2013-11-20 黑龙江八一农垦大学 一种人松弛素2前体及其制备方法
US9393288B2 (en) 2012-05-29 2016-07-19 The University Of Vermont And State Agricultural College Methods of treating diseases associated with PPARγ
US9907833B2 (en) 2013-07-25 2018-03-06 University Of Florida Research Foundation, Incorporated Use of relaxin to treat placental syndromes
AU2014318579A1 (en) 2013-09-13 2016-04-14 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
WO2015073727A1 (en) 2013-11-13 2015-05-21 Aequus Biopharma, Inc. Engineered glycoproteins and uses thereof
KR102455171B1 (ko) 2013-12-18 2022-10-14 더 스크립스 리서치 인스티튜트 변형된 치료제, 스테이플드 펩티드 지질 접합체, 및 이의 조성물
SG11201605273XA (en) * 2014-02-03 2016-08-30 Novartis Ag Filters for infusion sets
WO2016054792A1 (en) * 2014-10-09 2016-04-14 Cathay R&D Center Co., Ltd. Expression of recombinant tetracycline efflux pumps for the production of lysine or lysine-derived products, and methods and applications thereof
CN107417787B (zh) * 2016-05-23 2020-11-17 江苏恒瑞医药股份有限公司 一种人松弛素2类似物的制备方法
US10266578B2 (en) 2017-02-08 2019-04-23 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
CA3163507A1 (en) 2019-12-04 2021-06-10 The Scripps Research Institute Peptide conjugates and methods of use
IL309067A (en) 2021-06-09 2024-02-01 Scripps Research Inst Long-acting dual gip/glp-1 peptide conjugates and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068375A3 (de) * 1981-06-22 1983-04-13 G.D. Searle & Co. Rekombinante DNS Technik zur Herstellung von Relaxin
US4656249A (en) * 1982-06-10 1987-04-07 Howard Florey Institute Of Experimental Physiology And Medicine Peptides with relaxin activity
AU561670B2 (en) * 1982-06-10 1987-05-14 Howard Florey Institute Of Experimental Physiology And Medicine Peptides with relaxin activity
IL69469A (en) * 1982-08-12 1991-06-10 Florey Howard Inst Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
US5145962A (en) * 1982-08-12 1992-09-08 Howard Florey Institute Of Experimental Physiology And Medicine Human pro relaxin polypeptides
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
US5179195A (en) * 1982-12-13 1993-01-12 Howard Florey Institute Of Experimental Physiology And Medicine Human relaxin polypeptides
IL70414A (en) * 1982-12-13 1991-06-10 Florey Howard Inst Polypeptide having human h2-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
JPS63230089A (ja) * 1987-03-18 1988-09-26 Takeda Chem Ind Ltd 分泌発現による蛋白質の製造法
US5304473A (en) * 1991-06-11 1994-04-19 Eli Lilly And Company A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy

Also Published As

Publication number Publication date
EP0707650A1 (de) 1996-04-24
US5759807A (en) 1998-06-02
WO1995000645A3 (en) 1995-02-09
CA2165781C (en) 2007-02-13
EP0707650B1 (de) 2003-05-21
DE69432704T2 (de) 2004-02-26
AU691189B2 (en) 1998-05-14
DE69432704D1 (de) 2003-06-26
AU7176594A (en) 1995-01-17
CA2165781A1 (en) 1995-01-05
JP2007014342A (ja) 2007-01-25
JP3954091B2 (ja) 2007-08-08
JPH09501911A (ja) 1997-02-25
WO1995000645A2 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
DE69432704D1 (de) Verfahren zur Herstellung von humanen Relaxin
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
DE69101775D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid.
DE58908534D1 (de) Verfahren zur Herstellung von doppelt-haploiden Gurken.
DE69409148D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid
DE69611658D1 (de) Verfahren zur Herstellung von Ethylenglykol
DE69606495D1 (de) Verfahren zur Herstellung von depolymerisiertem Naturkautschuk
DE69132176D1 (de) Verfahren zur Herstellung von Elektroden
DE69407653D1 (de) Verfahren zur Herstellung von Wasserstoffsuperoxyd
ATE81339T1 (de) Verfahren zur herstellung von zyklischen sulfaten.
DE69424024D1 (de) Verfahren zur Herstellung von Laktamen
DE69429316D1 (de) Verfahren zur Herstellung von oxydierter Weisslauge
DE69008606D1 (de) Verfahren zur Herstellung von Carbamaten.
DE69414211D1 (de) Verfahren zur Herstellung von Fluorchemikalien
DE59003282D1 (de) Verfahren zur Herstellung von Dawsonit.
DE59300418D1 (de) Verfahren zur Herstellung von natürlichen Antioxidantien.
DE69314445D1 (de) Verfahren zur Herstellung von Wasserstoffperoxyd
DE69605064D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid
DE69023991D1 (de) Verfahren zur Herstellung von Chlortrifluorethylen.
DE69609882D1 (de) Verfahren zur Herstellung von normalen und überbasischen Phenolaten
DE69015814D1 (de) Verfahren zur Herstellung von Calciumhypochlorit.
DE69015152D1 (de) Verfahren zur Herstellung von Chlordioxyd.
ATE67986T1 (de) Verfahren zur herstellung von wasserstoffperoxid.
DE69603243D1 (de) Verfahren zur Herstellung von Ethenylamiden
DE69611331D1 (de) Verfahren zur Herstellung von S-Phenyl-L-Cystein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0707650

Country of ref document: EP